Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A market cap is $1.37B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A 52 week high is $22.09 as of May 03, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A 52 week low is $12.94 as of May 03, 2024.
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A stock price today is $20.08.
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A stock price yesterday was $19.38.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A’s P/E ratio is 178.95.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A P/B ratio is 2.9802.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A's EBITDA is -42.91.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A 50-day moving average is $19.16.
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A has 297 employees.